Am. J. Respir. Crit. Care Med., Vol 150, No. 5, Nov 1994, 1391-1401.
Dexamethasone and oxytetracycline reverse the potentiation of neurogenic inflammation in airways of rats with Mycoplasma pulmonis infection
JJ Bowden, TR Schoeb, JR Lindsey and DM McDonald
Cardiovascular Research Institute, University of California, San Francisco 94143-0130.
Mycoplasma pulmonis infection in rats causes a chronic inflammatory airway
disease. Along with extensive remodeling of the airway mucosa, lymphocytic
infiltrates, angiogenesis, and mucosal thickening, there is an abnormal
sensitivity of the blood vessels to mediators that evoke "neurogenic
inflammation". As a result, substance P, a peptide released from sensory
nerves, produces an unusually large amount of plasma leakage. These changes
can be prevented or reduced by prophylactic treatment with antibiotics, but
it is unknown whether the extensive remodeling of the airway mucosa and
potentiation of neurogenic inflammation can be reversed once they are
established. We addressed this issue in F344 rats that were infected with
M. pulmonis at 8 wk of age. Six weeks later, the rats were treated daily
with an antibiotic (oxytetracycline, 20 mg/kg intramuscularly), to reduce
the number of infecting organisms, or with an antiinflammatory steroid
(dexamethasone, 0.5 mg/kg intraperitoneally), to reduce the inflammatory
and immunologic response to the infection. Sham-treated infected rats
received daily injections of 0.9% NaCl. After 1, 2, or 4 wk of treatment
the rats were anesthetized and then challenged with substance P (5
micrograms/kg intravenously). The sham-treated rats had pathologic changes
in their airways typical of severe M. pulmonis infection, and had as much
as a threefold increase in substance P- induced plasma leakage. By
comparison, after 4 wk of treatment with oxytetracycline or dexamethasone,
the chronic inflammation was nearly resolved and the response to substance
P was in the normal range. Unexpectedly, dexamethasone, like
oxytetracycline, reduced the number of infecting organisms.(ABSTRACT
TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
N. Nisar, R. Guleria, S. Kumar, T. Chand Chawla, and N. Ranjan Biswas
Mycoplasma pneumoniae and its role in asthma
Postgrad. Med. J.,
February 1, 2007;
83(976):
100 - 104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. McDonald and P. Baluk
Imaging of Angiogenesis in Inflamed Airways and Tumors: Newly Formed Blood Vessels Are Not Alike and May Be Wildly Abnormal: Parker B. Francis Lecture
Chest,
December 1, 2005;
128(6_suppl):
602S - 608S.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Aurora, P. Baluk, D. Zhang, S. S. Sidhu, G. M. Dolganov, C. Basbaum, D. M. McDonald, and N. Killeen
Immune Complex-Dependent Remodeling of the Airway Vasculature in Response to a Chronic Bacterial Infection
J. Immunol.,
November 15, 2005;
175(10):
6319 - 6326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Boushey
New and Exploratory Therapies for Asthma
Chest,
March 1, 2003;
123(2007):
439S - 445S.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Hardy, H. S. Jafri, K. Olsen, J. Hatfield, J. Iglehart, B. B. Rogers, P. Patel, G. Cassell, G. H. McCracken, and O. Ramilo
Mycoplasma pneumoniae Induces Chronic Respiratory Infection, Airway Hyperreactivity, and Pulmonary Inflammation: a Murine Model of Infection-Associated Chronic Reactive Airway Disease
Infect. Immun.,
February 1, 2002;
70(2):
649 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. MCDONALD
Angiogenesis and Remodeling of Airway Vasculature in Chronic Inflammation
Am. J. Respir. Crit. Care Med.,
November 15, 2001;
164(10):
S39 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. W. Chu, M. Kraft, M. D. Rex, and R. J. Martin
Evaluation of Blood Vessels and Edema in the Airways of Asthma Patients : Regulation With Clarithromycin Treatment
Chest,
August 1, 2001;
120(2):
416 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ezaki, P. Baluk, G. Thurston, A. La Barbara, C. Woo, and D. M. McDonald
Time Course of Endothelial Cell Proliferation and Microvascular Remodeling in Chronic Inflammation
Am. J. Pathol.,
June 1, 2001;
158(6):
2043 - 2055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Martin, H. W. Chu, J. M. Honour, and R. J. Harbeck
Airway Inflammation and Bronchial Hyperresponsiveness after Mycoplasma pneumoniae Infection in a Murine Model
Am. J. Respir. Cell Mol. Biol.,
May 1, 2001;
24(5):
577 - 582.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Casale
Immunobiology of Asthma and Rhinitis . Pathogenic Factors and Therapeutic Options
Am. J. Respir. Crit. Care Med.,
November 1, 1999;
160(5):
1778 - 1787.
[Full Text]
|
 |
|

|
 |

|
 |
 
S. R. Akhter, H. Ikezaki, X.-P. Gao, and I. Rubinstein
Dexamethasone attenuates grain sorghum dust extract-induced increase in macromolecular efflux in vivo
J Appl Physiol,
May 1, 1999;
86(5):
1603 - 1609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dahlqvist, E. Y. Umemoto, J. J. Brokaw, M. Dupuis, and D. M. McDonald
Tissue Macrophages Associated with Angiogenesis in Chronic Airway Inflammation in Rats
Am. J. Respir. Cell Mol. Biol.,
February 1, 1999;
20(2):
237 - 247.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. H. K. Lim, B. S. Bochner, and E. M. Wagner
Leukocyte recruitment in the airways: an intravital microscopic study of rat tracheal microcirculation
Am J Physiol Lung Cell Mol Physiol,
May 1, 2002;
282(5):
L959 - L967.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1994 American Thoracic Society
|
|
|